InflaRx N.V.(IFRX)

$2.23—Stale · unknown old

Chart

InflaRx N.V.(IFRX)

NASDAQ • Last print unknown ago

$2.23—Stale · unknown old

Chart Studio

IFRX(IFRX)

IFRX

Overview Fair Value Stream Notebook Intel Chart History Fundamentals TTM Earnings Analysts News Financials Insiders Institl.DCF Peers

Q4 2026 EPS Estimate

$-0.07

Nov 9, 2026 · Reports before open

Revenue Estimate

$6,061

Analyst Sentiment

Wall St. Consensus

Buy

16 analysts·Moderate coverage

Score

13 Buy (81%)2 Hold (13%)1 Sell (6%)

Rating Breakdown

Strong Buy

16%

Buy

1275%

Hold

213%

Sell

16%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$9.00

+303.6%

Consensus

$9.00

+303.6%

Bull

$9.00

+303.6%

12-Month Target Range16 analysts

$9.00$9.00$9.00

Current $2.23Consensus

Current Price

$2.23

Upside to Consensus

$6.77

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+30.65%

EPS—

FY2028

Rev-28.80%

EPS—

FY2029

Rev+1141086.75%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	$12,524	$16,362	$11,650	$133M	$235M
Low	$12,524	$16,362	$11,650	$133M	$235M
High	$12,524	$16,362	$11,650	$133M	$235M
EBITDA Avg	$-19M	$-23M	$-29M	$-5M	$29M
Low	$-21M	$-34M	$-29M	$-5M	$29M
High	$-14M	$-16M	$-29M	$-5M	$29M
EBIT Avg	$-19M	$-24M	$-29M	$-17M	$-2M
Low	$-21M	$-34M	$-29M	$-17M	$-2M
High	$-15M	$-16M	$-29M	$-17M	$-2M
Net Income Avg	$-19M	$-24M	$-29M	$-17M	$-2M
Low	$-21M	$-34M	$-29M	$-17M	$-2M
High	$-15M	$-16M	$-29M	$-17M	$-2M
EPS Avg	$-0.28	$-0.35	$-0.43	$-0.26	$-0.04
Low	$-0.32	$-0.51	$-0.43	$-0.26	$-0.04
High	$-0.22	$-0.24	$-0.43	$-0.26	$-0.04
Analysts (Rev / EPS)	3 / 4	3 / 4	1 / 2	1 / 1	2 / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027
Revenue Avg	$5,302	$5,050	—	—	—	—
Low	$5,302	$5,050	—	—	—	—
High	$5,302	$5,050	—	—	—	—
EBITDA Avg	$-7M	$-7M	—	—	—	—
Low	$-8M	$-9M	—	—	—	—
High	$-6M	$-6M	—	—	—	—
EBIT Avg	$-7M	$-7M	—	—	—	—
Low	$-9M	$-9M	—	—	—	—
High	$-6M	$-6M	—	—	—	—
Net Income Avg	$-7M	$-7M	$-8M	$-10M	$-10M	$-11M
Low	$-9M	$-9M	$-8M	$-10M	$-10M	$-11M
High	$-6M	$-6M	$-8M	$-10M	$-10M	$-11M
EPS Avg	$-0.06	$-0.06	$-0.07	$-0.08	$-0.09	$-0.10
Low	$-0.07	$-0.08	$-0.07	$-0.08	$-0.09	$-0.10
High	$-0.05	$-0.05	$-0.07	$-0.08	$-0.09	$-0.10
Analysts (Rev / EPS)	4 / 4	2 / 4	— / 1	— / 1	— / 1	— / 1

Earnings Surprises

Recent Analyst Actions

May 13, 2026Raymond James

InflaRx upgraded to Strong Buy from Outperform at Raymond James

Target:$9.00

+254.1%from $2.54

Dec 3, 2025Leerink Partners

InflaRx downgraded to Market Perform from Outperform at Leerink

Target:$2.00

+101.2%from $0.99

May 29, 2025Raymond James

InflaRx downgraded to Outperform from Strong Buy at Raymond James

Target:$2.00

+135.3%from $0.85

Jan 6, 2023H.C. Wainwright

HC Wainwright & Co. Maintains Buy on InflaRx, Lowers Price Target to $6

Target:$6.00

+105.5%from $2.92

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance